TAILIEUCHUNG - Báo cáo khoa học: Regulation of secretases by all-trans-retinoic acid

One of the emerging approaches for the treatment of Alzheimer’s disease aims at reducing toxic levels of Ab-species through the modulation of secretases, namely by inducing a-secretase or inhibiting b-secretase and⁄or c-secretase activities, or a combination of both. | ỊFEBS Journal Regulation of secretases by all-trans-retinoic acid Anna Koryakina Jessica Aeberhard Sabine Kiefer Matthias Hamburger and Peter Kuenzi Institute of PharmaceuticalBiology University of Basel Switzerland Keywords Alzheimer s disease PDBu phorbol-12 13-dibutyrate PKC protein kinase C retinoic acid secretases Correspondence P. Kuenzi Institute of Pharmaceutical Biology University of Basel Klingelbergstrasse 50 4056 Basel Switzerland Fax 41 61 267 14 74 Tel 41 61 267 15 44 E-mail Received 12 January 2009 revised 19 February 2009 accepted 4 March 2009 doi One of the emerging approaches for the treatment of Alzheimer s disease aims at reducing toxic levels of Ab-species through the modulation of secretases namely by inducing a-secretase or inhibiting b-secretase and or y-secretase activities or a combination of both. Although there is increasing evidence for the involvement of retinoids in Alzheimer s disease their significance in the regulation of Ab-peptide production remains unresolved. Our work concentrated on the regulation of all secretases mediated by all-trans-retinoic acid ATRA and supports the hypothesis that ATRA is capable of regulating them in an antiamyloidogenic sense at the levels of transcription translation and activation. Apart from increased a-secretase activity we show a complex chain of regulatory events resulting in impaired b-secretase trafficking and membrane localization upon protein kinase C PKC activation by ATRA. Furthermore ATRA demonstrates substrate specificity for b-site amyloid precursor protein-cleaving enzyme BACE 1 over nonamyloidogenic BACE2 in b-secretase regulation which probably promotes competition for amyloid precursor protein between ADAM17 and BACE1. Additionally we report enhanced secretion of soluble amyloid precursor protein a after ATRA exposure possibly due to PKC activation as pretreatment with the PKC inhibitor Go6976 abolished all these events. The .

TỪ KHÓA LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.